Literature DB >> 18620752

Erythropoietin and cancer, a double-edged sword.

Domenico Ribatti.   

Abstract

This editorial is focused on the double controversial action of erythropoietin, acting as anticancer agent and as a promoting cancer agent.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18620752     DOI： 10.1016/j.leukres.2008.06.004

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


  2 in total

1.  Erythropoietin neuroprotection with traumatic brain injury.

Authors:  Lucido L Ponce; Jovany Cruz Navarro; Osama Ahmed; Claudia S Robertson
Journal:  Pathophysiology       Date:  2012-03-14

Review 2.  Erythropoietin or darbepoetin for patients with cancer.

Authors:  Thomy Tonia; Annette Mettler; Nadège Robert; Guido Schwarzer; Jerome Seidenfeld; Olaf Weingart; Chris Hyde; Andreas Engert; Julia Bohlius
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.